Adamas Pharmaceuticals Inc 4 SEC Filings

Filed On	Filing
24 Nov 2021	Form 4: Bigham Michael, Director Disposed of 10,000 shares (Tender Offer) · Disposed of 30,000 Stock Option (Right to Buy) (Disposition to Issuer)
24 Nov 2021	Form 4: Mahoney David L, Director Disposed of 117,781 shares (Tender Offer) · Disposed of 70,000 Stock Option (Right to Buy) (Disposition to Issuer)
24 Nov 2021	Form 4: McFarlane Neil F., Director Received 75,000 shares as a grant or award · Disposed of 600,000 shares (Tender Offer) · Disposed of 450,000 Stock Option (Right to Buy) (Disposition to Issuer)
24 Nov 2021	Form 4: Prentiss Christopher B, Chief Financial Officer Received 18,750 shares as a grant or award · Disposed of 163,767 shares (Tender Offer) · Disposed of 87,500 Stock Option (Right to Buy) (Disposition to Issuer)
24 Nov 2021	Form 4: Ericson William W., Director Disposed of 4,629,796 shares (Tender Offer) · Disposed of 30,000 Stock Option (Right to Buy) (Disposition to Issuer)
24 Nov 2021	Form 4: Shreedhar Vijay, Chief Commercial Officer Received 18,750 shares as a grant or award · Disposed of 186,786 shares (Tender Offer) · Disposed of 185,000 Stock Option (Right to Buy) (Disposition to Issuer)
24 Nov 2021	Form 4: Papapetropoulos Spyridon, Director Disposed of 20,975 shares (Tender Offer) · Disposed of 30,000 Stock Option (Right to Buy) (Disposition to Issuer)
24 Nov 2021	Form 4: Richo Anna, Director Disposed of 25,000 shares (Tender Offer) · Disposed of 30,000 Stock Option (Right to Buy) (Disposition to Issuer)
24 Nov 2021	Form 4: Demski Martha J, Director Disposed of 21,000 shares (Tender Offer) · Disposed of 30,000 Stock Option (Right to Buy) (Disposition to Issuer)
24 Nov 2021	Form 4: MacPhee John A, Director Disposed of 202,000 shares (Tender Offer) · Disposed of 54,000 Stock Option (Right to Buy) (Disposition to Issuer)
23 Jun 2021	Form 4: Shreedhar Vijay, Chief Commercial Officer Sold 6,200 shares ($32K)
08 Jun 2021	Form 4: Demski Martha J, Director Sold 2,000 shares ($10.3K)
04 Jun 2021	Form 4: Richo Anna, Director Received 5,000 shares as a grant or award · Granted 10,000 Stock Option (Right to Buy)
04 Jun 2021	Form 4: Papapetropoulos Spyridon, Director Received 5,000 shares as a grant or award · Granted 10,000 Stock Option (Right to Buy)
04 Jun 2021	Form 4: Mahoney David L, Director Received 5,000 shares as a grant or award · Granted 10,000 Stock Option (Right to Buy)
04 Jun 2021	Form 4: MacPhee John A, Director Received 5,000 shares as a grant or award · Granted 10,000 Stock Option (Right to Buy)
04 Jun 2021	Form 4: Ericson William W., Director Received 5,000 shares as a grant or award · Granted 10,000 Stock Option (Right to Buy)
04 Jun 2021	Form 4: Dier Mardi, Director Received 5,000 shares as a grant or award · Granted 10,000 Stock Option (Right to Buy)
04 Jun 2021	Form 4: Demski Martha J, Director Received 5,000 shares as a grant or award · Granted 10,000 Stock Option (Right to Buy)
04 Jun 2021	Form 4: Bigham Michael, Director Received 5,000 shares as a grant or award · Granted 10,000 Stock Option (Right to Buy)

Comments